Document is current

Any future updates will be listed below

Pelvic lymph node dissection in prostate cancer, still no level 1 evidence of oncological benefit. Time to consider surveillance of negative pelvic lymph nodes on PSMA PET scan staging

Crossref DOI link: https://doi.org/10.1038/s41391-025-01065-5

Published Online: 2025-12-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark